Investor insights
Sectors invested in
Funding rounds participated in
$40M sweet spot round size
Most of their 7 investments are in rounds between $21M and $41M
Basic info
Industry
Sectors
Date founded
2014
Investments made
Lokavant raised $21M on December 7, 2022
Investors: Edison Partners and Roivant Sciences
Medallion raised $30M on November 3, 2021
Investors: Optum Ventures, Spark Capital and Roivant Sciences
gen-t raised $2M on November 1, 2021
Investors: Roivant Sciences
Immunovant raised $200M on August 2, 2021
Investors: Frazier Healthcare Partners and Roivant Sciences
Datavant raised $40M on October 8, 2020
Investors: Cigna Ventures, Flex Capital, Leerink Transformation Partners and Roivant Sciences
Datavant raised $41M on April 30, 2018
Investors: Founders Fund, SoftBank Investment Advisers and Roivant Sciences
Tekmira Pharmaceutical Corporation raised $116M on October 2, 2017
Investors: Roivant Sciences
Funding rounds raised
Total raised
$1.1B
from 20 investors over 20 rounds
Roivant Sciences raised $200M on October 1, 2021
Investors: Suvretta Capital Management LLC, Patient Square Capital, Dainippon Sumitomo Pharma, Palantir Technologies, Viking Global Investors, Eventide Asset Management and RTW Investments, LP
Roivant Sciences raised $200M on November 13, 2018
Investors: Founders Fund, Dexcel Pharma, -, QVT Financial LLP, RTW Investments, LP, SoftBank Investment Advisers and Viking Global Investors
Roivant Sciences raised $1.1B on August 9, 2017
Investors: Founders Fund and SoftBank Investment Advisers
Roivant Sciences raised $500M on July 13, 2016
Investors: Viking Global Investors
Roivant Sciences raised $93M on May 1, 2014
Investors: Sahsen Ventures, LLC, QVT Financial LLP and Dexcel Pharma